Heidi S. Harvie, MD, MBA, MSCE
Urogynecology

Heidi S. Harvie, MD, MBA, MSCE

she/her/hers
Urogynecology
Accepting new patients
Sees patients age 16 and up
Penn Urogynecology Washington Square
Penn Medicine Provider

About me

  • Chief, Division of Urogynecology & Pelvic Reconstructive Surgery
  • Director, Penn Urogynecology & Pelvic Reconstructive Surgery, Pennsylvania Hospital
  • Associate Professor of Obstetrics and Gynecology at the Pennsylvania Hospital

My education and training

  • University of Pennsylvania School of MedicineMedical School
  • University of Pennsylvania Health SystemResidency
  • University of Pennsylvania Health SystemFellowship

Spoken languages

English
English

Reviews

Average Rating

560 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
October 2026
I felt confident in the knowledge, skill and empathy of Dr. Harvie.
Anonymous
October 2026
Heidi helps you to appreciate that a woman doesn't have to continue living with these type of issues.
Anonymous
October 2026
Dr Harvie has a very down to earth personality but extremely knowledgeable and takes the time to explain step by step and is detailed oriented. I'm sure she sees patients all day and must run on time but i never felt rushed
Anonymous
September 2026
Knowledgeable, professional

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
Dr. Harvie is a Penn Medicine provider.

Qualifications and experience

All conditions and treatments

Research

Publications

Nager, C. W., Visco, A. G., Richter, H. E., Rardin, C. R., Meriwether, K., Harvie, H. S., Zyczynski, H. M., Paraiso, M. F. R., Mazloomdoost, D., Sridhar, A., Thomas, S., & Eunice Kennedy Shriver NICHD Pelvic Floor Disorders Network Sacrospinous Hysteropexy With Mesh vs Vaginal Hysterectomy for Treatment of Uterovaginal Prolapse: 10-Year Results of a Randomized Clinical Trial. , JAMA Surg, 161(8): 2026,764-774


Gilmore E, McAllister A, Russell LB, Montoya M, Koelper NC, Schreiber CA, Harvie HS Validity and Responsiveness of EQ-5D-5L in the Abortion Care Setting. , American J Obstet Gynecol, 234(4): 2026,1121–1129


Agrawal S, Ikpeama N, Koelper N, Dokras A, Harvie H, Hamm RF, Dutcher L, Arya LA A Randomized Trial of a Texting Platform for Recurrent Urinary Tract Infections. , Urogynecology, 32(3): 2026,62–171


Lukacz ES, Menefee SA, Carper B, Collins S, McMillian K, Florian-Rodriguez M, Rardin C, Weidner AC, Harvie HS, Alexander B, Mazloomdoost D, NICHD Pelvic Floor Disorders Network Design of Transurethral Bulking Agent Injection Versus Single-Incision SlingTrial. , Urogynecology, 32(2): 2026,131–141


Shinnick, J. K., Sung, V. W., Lukacz, E. S., Chermansky, C., Harvie, H. S., Ellington, D., Paraiso, M. F., Yu, S., Mazloomdoost, D., Carper, B., Rogers, R. G., & NICHD Pelvic Floor Disorders Network Goal Achievement in Women With Urinary Incontinence After Midurethral Sling , Urogynecology: 2026


Kreines FM, Cox C, Mumford SL, Harvie HS, Arya LA, Andy UU. Gender-Affirming Testosterone Treatment and Lower Urinary Tract Symptoms , Urogynecology: 2026


Harvie HS, Honeycutt AA, Carper B, Menefee S, Siddiqui N, Ellington D, Rardin C, Jeney SE, Glass Clark S, Mazloomdoost D, Thomas S, for the NICHD Pelvic Floor Disorders Network Cost Effectiveness of vaginal mesh hysteropexy vs hysterectomy/USLS: SUPeR Trial. , Urogynecology: 2026


Harvie HS, Chermansky C, Richter HE Midurethral Sling vs OnabotulinumtoxinA for Urinary Incontinence-Reply , JAMA, 334(16): 2025,1488-1489


Muñoz JM, Kim EK, Andy UU, Mumford SL, Harvie HS Variation in Overactive Bladder Treatment Type by Social Determinants of Health. , Urogynecology, 31(10): 2025,929-941


Reaves S, Levin, PJ, Harvie HS, Andy UU Factors Affecting Follow-up for Specialty Postpartum Care after Obstetric Anal Sphincter Injury at a Single U.S. Institution. , Int Urogynecol J, 36(7): 2025,1457-1463